NASDAQ : CHRD
$5.4 (4.11%)
| Date | Grading Company | Previous Grade | New Grade | Action |
|---|---|---|---|---|
| 2026-07-10 | UBS | Buy | Buy | Maintain |
| 2026-07-10 | Citigroup | Neutral | Neutral | Maintain |
| 2026-07-07 | Truist Securities | Buy | Buy | Maintain |
| 2026-06-29 | Morgan Stanley | Overweight | Overweight | Maintain |
| 2026-05-27 | Mizuho | Outperform | Outperform | Maintain |
| 2026-05-22 | Morgan Stanley | Overweight | Overweight | Maintain |
| 2026-05-08 | Truist Securities | Buy | Buy | Maintain |
| 2026-05-07 | UBS | Buy | Buy | Maintain |
| 2026-05-06 | Mizuho | Outperform | Outperform | Maintain |
| 2026-04-22 | Scotiabank | Sector Perform | Sector Perform | Maintain |
| 2026-04-17 | Roth Capital | Buy | Buy | Maintain |
| 2026-04-13 | Truist Securities | Buy | Buy | Maintain |
| 2026-04-08 | Wells Fargo | Overweight | Overweight | Maintain |
| 2026-03-31 | Citigroup | Neutral | Neutral | Maintain |
| 2026-03-27 | Morgan Stanley | Equal Weight | Overweight | Upgrade |
| 2026-03-24 | Truist Securities | Buy | Buy | Maintain |
| 2026-03-16 | Wells Fargo | Overweight | Overweight | Maintain |
| 2026-03-12 | Piper Sandler | Overweight | Overweight | Maintain |
| 2026-03-06 | Citigroup | Neutral | Neutral | Maintain |
| 2026-03-05 | UBS | Buy | Buy | Maintain |
| 2026-03-05 | Piper Sandler | Overweight | Overweight | Maintain |
| 2026-02-11 | Piper Sandler | Overweight | Overweight | Maintain |
| 2026-01-28 | Piper Sandler | Overweight | Overweight | Maintain |
| 2026-01-27 | Wells Fargo | Overweight | Overweight | Maintain |
| 2026-01-23 | Morgan Stanley | Equal Weight | Equal Weight | Maintain |
| 2026-01-14 | Citigroup | Buy | Neutral | Downgrade |
| 2026-01-13 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-01-09 | UBS | Buy | Buy | Maintain |